Sofinnova Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-56,915
| Closed | -$2.98M | – | 75 |
|
|
2021
Q4 | $2.98M | Sell |
56,915
-170,504
| -75% | -$8.92M | 0.17% | 52 |
|
|
2021
Q3 | $8.48M | Sell |
227,419
-85,740
| -27% | -$3.2M | 0.5% | 38 |
|
|
2021
Q2 | $12.8M | Sell |
313,159
-341,842
| -52% | -$14M | 0.74% | 32 |
|
|
2021
Q1 | $22.2M | Sell |
655,001
-193,161
| -23% | -$6.55M | 1.34% | 20 |
|
|
2020
Q4 | $27M | Buy |
848,162
+344,607
| +68% | +$11M | 1.61% | 15 |
|
|
2020
Q3 | $12.9M | Buy |
503,555
+261,647
| +108% | +$6.71M | 0.96% | 21 |
|
|
2020
Q2 | $6.21M | Buy |
241,908
+189,903
| +365% | +$4.87M | 0.39% | 43 |
|
|
2020
Q1 | $800K | Buy |
+52,005
| New | +$800K | 0.07% | 57 |
|
|
2019
Q3 | – | Sell |
-125,955
| Closed | -$1.64M | – | 76 |
|
|
2019
Q2 | $1.64M | Buy |
+125,955
| New | +$1.64M | 0.15% | 55 |
|